Europe • Frankfurt Stock Exchange • FRA:IX1 • US45168D1046
The current stock price of IX1.DE is 566.6 EUR. In the past month the price decreased by -4.03%. In the past year, price increased by 40.81%.
ChartMill assigns a technical rating of 8 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE is one of the better performing stocks in the market, outperforming 91.97% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to IX1.DE. IX1.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 10.65. The EPS increased by 15.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.65% | ||
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| Debt/Equity | 0.53 |
22 analysts have analysed IX1.DE and the average price target is 663.13 EUR. This implies a price increase of 17.04% is expected in the next year compared to the current price of 566.6.
For the next year, analysts expect an EPS growth of 16.89% and a revenue growth 10.46% for IX1.DE
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.28 | 111.57B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.75 | 108.30B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.82 | 48.04B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.73 | 23.84B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.53 | 23.55B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.46 | 23.46B | ||
| BIM.PA | BIOMERIEUX | 25.04 | 11.44B | ||
| DIA.MI | DIASORIN SPA | 21.84 | 4.04B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 130.11 | 3.91B | ||
| 1AFX.MI | CARL ZEISS MEDITEC AG - BR | 17.45 | 2.51B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 17.3 | 2.49B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 13.64 | 1.65B |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE US
Employees: 11000
Phone: 12075560300
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
The current stock price of IX1.DE is 566.6 EUR. The price decreased by -0.25% in the last trading session.
IX1.DE does not pay a dividend.
IX1.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
22 analysts have analysed IX1.DE and the average price target is 663.13 EUR. This implies a price increase of 17.04% is expected in the next year compared to the current price of 566.6.
IDEXX LABORATORIES INC (IX1.DE) has a market capitalization of 45.24B EUR. This makes IX1.DE a Large Cap stock.
IDEXX LABORATORIES INC (IX1.DE) will report earnings on 2026-02-02, before the market open.